This product is for research use only, not for human use. We do not sell to patients.
Size | Price | Stock |
---|---|---|
250mg | $710 | Check With Us |
500mg | $999 | Check With Us |
1g | $1495 | Check With Us |
Cat #: V0059 CAS #: 1337531-36-8 Purity ≥ 98%
Description: GSK2606414 is a novel, potent and selective inhibitor of PERK (PRKR-like endoplasmic reticulum kinase or protein kinase R (PKR)-like endoplasmic reticulum kinase) with IC50 of 0.4 nM, displaying at least 100-fold selectivity over the other EIF2AKs assayed.
Publications Citing InvivoChem Products
Product Promise
- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
Molecular Weight (MW) | 451.44 |
---|---|
Molecular Formula | C24H20F3N5O |
CAS No. | 1337531-36-8 |
Storage | -20℃ for 3 years in powder formr |
-80℃ for 2 years in solvent | |
Solubility In Vitro | DMSO: 90 mg/mL (199.36 mM)r |
Water: <1 mg/mL (slightly soluble or insoluble)r | |
Ethanol: 19 mg/mL (42.08 mM) | |
SMILES Code | FC(C1=CC(CC(N2CCC3=C2C=CC(C4=CN(C)C5=NC=NC(N)=C54)=C3)=O)=CC=C1)(F)F |
Synonyms | GSK PERK Inhibitor; GSK2606414; GSK-2606414; GSK 2606414; |
Protocol | In Vitro | GSK2606414 inhibits PERK activation in cells. |
---|---|---|
In Vivo | GSK2606414 (50 and 150 mg/kg, p.o.) inhibits the growth of a human tumor xenograft in mice. |
Solvent volume to be added | Mass (the weight of a compound) | |||
---|---|---|---|---|
Mother liquor concentration | 1mg | 5mg | 10mg | 20mg |
1mM | 2.2151 mL | 11.0757 mL | 22.1513 mL | 44.3027 mL |
5mM | 0.4430 mL | 2.2151 mL | 4.4303 mL | 8.8605 mL |
10mM | 0.2215 mL | 1.1076 mL | 2.2151 mL | 4.4303 mL |
20mM | 0.1108 mL | 0.5538 mL | 1.1076 mL | 2.2151 mL |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.